Reviva Pharmaceuticals Holdings, Inc. (RVPH) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 3.27M | 3.56M | 4.03M | 6.07M | 6.54M | 6.28M | 8.46M | 8.13M | 7.92M | 9.99M | 10.71M | 12.07M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.84M | 1.82M | 1.9M | 2.35M | 2.42M | 1.6M | 1.6M | 2.55M | 2.14M | 1.51M | 1.99M | 3.08M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.44M | 1.74M | 2.13M | 3.72M | 4.11M | 4.68M | 6.86M | 5.58M | 5.78M | 8.48M | 8.72M | 8.99M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.19K | -19 |
| Operating Income | -3.27M | -3.56M | -4.03M | -6.07M | -6.54M | -6.28M | -8.46M | -8.13M | -7.92M | -9.99M | -10.71M | -12.07M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 49.96% | 43.37% | 52.38% | 25.3% | 17.47% | 37.08% | 20.98% | 32.65% | -17.62% | -28.49% | -200.57% | -118.69% |
| EBITDA | -3.19M | -3.37M | -4.01M | -6.04M | -6.42M | -7.07M | 0 | -7.85M | -7.42M | -10.01M | -10.61M | -11.97M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 50.24% | 52.3% | - | 23.02% | 13.56% | 29.4% | 100% | 34.43% | -12.41% | -36.88% | -200.13% | -110.05% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | -781.64K | 8.46M | 282.26K | 499.38K | 0 | 96.96K | 103.06K |
| EBIT | -3.19M | -3.37M | -4.01M | -6.04M | -6.42M | -6.25M | -8.36M | -7.85M | -7.42M | -10.01M | -10.71M | -12.07M |
| Net Interest Income | 82.7K | 143.31K | 56.5K | 18.05K | 74.49K | 42.7K | 48.1K | 82.46K | 169.61K | 49.15K | 85.86K | 90.32K |
| Interest Income | 89.35K | 143.31K | 59.1K | 22.85K | 86.11K | 47.41K | 53.25K | 87.61K | 173.1K | 56.56K | 91.76K | 103.08K |
| Interest Expense | 6.65K | 0 | 2.6K | 4.8K | 11.62K | 4.71K | 5.15K | 5.15K | 3.49K | 7.41K | 5.9K | 12.76K |
| Other Income/Expense | 79.31K | 194.24K | 21.91K | 27.33K | 110.54K | 29.86K | 96.74K | 277.11K | 495.89K | 259.5K | 144.27K | -456.2K |
| Pretax Income | -3.19M | -3.36M | -4.01M | -6.05M | -6.43M | -6.25M | -8.37M | -7.85M | -7.43M | -9.73M | -10.48M | -12.44M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 3.35K | 2.88K | 2.84K | 7.95K | 5.21K | 4.73K | 0 | 7.38K | 7.4K | -4.58K | 12.12K | 6.44K |
| Effective Tax Rate % | -0.1% | -0.09% | -0.07% | -0.13% | -0.08% | -0.08% | 0% | -0.09% | -0.1% | 0.05% | -0.12% | -0.05% |
| Net Income | -3.2M | -3.37M | -4.01M | -6.05M | -6.43M | -6.26M | -8.37M | -7.86M | -7.43M | -9.72M | -10.49M | -12.44M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 50.32% | 46.2% | 52.06% | 22.98% | 13.46% | 35.63% | 20.26% | 36.83% | -12.59% | -19.78% | -198.44% | -132.98% |
| Net Income (Continuing) | -3.2M | -3.37M | -4.01M | -6.05M | -6.43M | -6.26M | -8.37M | -7.86M | -7.43M | -9.72M | -10.49M | -12.44M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.46 | -5.21 | -1.10 | -2.40 | -2.60 | -3.20 | -5.00 | -5.20 | -5.00 | -7.20 | -8.73 | -11.09 |
| EPS Growth % | 82.31% | -62.81% | 77.92% | 53.85% | 48% | 55.56% | 42.73% | 53.12% | 17.33% | 9.32% | -139.31% | -91.77% |
| EPS (Basic) | -0.46 | -5.21 | -1.10 | -2.40 | -2.60 | -3.20 | -5.00 | -5.20 | -5.00 | -7.20 | -8.73 | -11.09 |
| Diluted Shares Outstanding | 7.02M | 3.63M | 3.63M | 2.49M | 2.43M | 1.66M | 1.69M | 1.53M | 1.49M | 1.36M | 1.2M | 1.12M |
| Basic Shares Outstanding | 7.02M | 3.63M | 3.63M | 2.49M | 2.43M | 1.66M | 1.69M | 1.53M | 1.49M | 1.36M | 1.2M | 1.12M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |